Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201103308 Principal Investigator: Linette, Gerald
Title: Mature Dendritic Vaccination Against gp100 in Patients with Advanced Melanoma
Description: You may be asked to participate in this study because you have been diagnosed with metastatic melanoma. Although there are treatments that can control your disease for a period of time, there are no treatments that have been shown to cure melanoma once it has spread to distant sites in the body (su...MORE
___________________________________________________________________________________________________
 Number: 201401045 Principal Investigator: Linette, Gerald
Title: A Randomized, Double-Blind Study to Assess the Efficacy of Selumetinib(AZD6244, Hyd-Sulfate) in Combination with Dacarbazine Compared with Placebo in Combination with Dacarbazine as First Systemic Therapy in Patients with Metastatic Uveal Melanoma (SUMIT)
Description: The purpose of this study is to see if selumetinib in combination with an established chemotherapy(dacarbazine) is more effective than the chemotherapy on its own in the treatment of metastatic uveal melanoma....MORE
___________________________________________________________________________________________________
 Number: 201312034 Principal Investigator: Linette, Gerald
Title: A Phase 1 Open-label Study of Safety and Tolerability of MEDI4736 in Subjects with Metastatic or Unresectable Melanoma in Combination with Dabrafenib and Trametinib or with Trametinib Alone
Description: The purpose of this research study is to determine the maximum dose of MEDI4736 in combination with dabrafenib and trametinib or trametinib alone that is tolerable in patients with metastatic or unresectable melanoma....MORE
___________________________________________________________________________________________________
 Number: 201306025 Principal Investigator: Linette, Gerald
Title: Phase 1 Study of the BRAF Inhibitor Dabrafenib +/- MEK Inhibitor Trametinib in Combination with Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma
Description: The purpose of this study is to test what doses of the GSK study medications dabrafenib with or without trametinib can be given safely in combination with ipilimumab....MORE
___________________________________________________________________________________________________
 Number: 201211040 Principal Investigator: Linette, Gerald
Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib (RO5185426) Adjuvant Therapy in Patients with Surgically Resected, Cutaneous BRAF-Mutant Melanoma at High Risk for Recurrence
Description: The purpose of this study is to find out whether vemurafenib can help prevent or delay the return of melanoma that is at a high risk of returning (Stage IIC, IIIA, IIIB or IIIC) after it has been removed surgically. The study will also assess whether the drug causes side effects in patients....MORE
___________________________________________________________________________________________________
 Number: 201205056 Principal Investigator: Linette, Gerald
Title: A Multicenter, Double-blind, Placebo-controlled, Adaptive Phase 3 Trial of POL-103A Polyvalent Melanoma Vaccine in Post-resection Melanoma Patients with a High Risk of Recurrence
Description: The purpose of this study is to determine how safe and how well POL-103A works in preventing the relapse of melanoma after patients have undergone surgery....MORE
___________________________________________________________________________________________________
 Number: 201010741 Principal Investigator: Linette, Gerald
Title: Phase I/II study to assess the safety and activity of enhanced TCR transduced autologous T cells against cancer-testis antigens in metastatic melanoma
Description: The purpose of this clinical trial is to assess the effects (both good and bad) of chemotherapy and treatment with modified T cells on cancer and general health....MORE
___________________________________________________________________________________________________
 Number: 201109292 Principal Investigator: Cornelius, Lynn
Title: Tissue Acquisition for Analysis of Genetic Factors in Melanoma and Other Skin Cancers
___________________________________________________________________________________________________
 Number: 201105020 Principal Investigator: Anadkat, Milan
Title: Retrospective and Prospective Data Collection and Analysis of Cutaneous Chemotherapy REACTions at Washington University
___________________________________________________________________________________________________